Owner JAPAN TOBACCO INC.

Inventors KATOH, Susumu; MIYAZAKI, Susumu; HABUKA, Noriyuki

Pub. Number AU-A-2002323963

PCT Number PCT/JP02/08211

PCT Pub. Number WO2003/016266

Priority 2001-247346 16.08.01 JP; 2001-372066 05.12.01 JP; 2002-151232 24.05.02 JP

Filing date 12 August 2002

Wipo publication date 3 March 2003

C07C 235/80 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07C 237/42 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 311/46 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 317/40 Sulfones

C07D 213/30 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/68 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/75 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/12 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/38 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 231/12 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/64 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/26 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 241/12 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 261/08 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 263/14 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 271/10 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 277/24 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/46 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 295/18 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/22 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/81 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 317/66 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms